---
document_datetime: 2025-05-12 09:40:09
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/aqumeldi-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: aqumeldi-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 1.0149067
conversion_datetime: 2025-12-28 04:53:18.001156
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Aqumeldi

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                           |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------------------------------|
| X/0001/G             | This was an application for a group of variations. Annex I_2.(c) Change or addition of a new strength/potency C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation | 27/02/2025                          | 23/04/2025                                  | SmPC, Labelling and PL           |                                   |
| PSUSA/201/2 02403    | Periodic Safety Update EU Single assessment - enalapril maleate (centrally authorised product for use in children below the age of 18)                                                                       | 31/10/2024                          | n/a                                         |                                  | PRAC Recommendation - maintenance |

<!-- image -->

<!-- image -->